PT / INR Test

Prothrombin Time (PT) measures how long blood takes to clot through part of the clotting pathway. INR standardizes PT results and is commonly used when monitoring certain anticoagulant medicines such as warfarin. The result must be interpreted using the target range set by the treating clinician.

Prothrombin time (PT) measures how long plasma takes to clot through part of the coagulation pathway. INR standardizes the PT result so it can be compared more consistently between laboratories and is especially important for monitoring warfarin therapy.

For someone not taking warfarin, the reference interval is close to an INR of 1.0. For someone taking warfarin, the desired INR is intentionally higher and depends on why the medicine is prescribed. The therapeutic target is therefore not a ‘normal range’ and must come from the treating clinician.

For someone taking warfarin, consistency and trend are often more important than one isolated INR. Changes in medicines, illness, diet, alcohol intake and adherence can alter anticoagulant effect. The treating service may repeat INR sooner when a result is outside the prescribed range. For people not taking warfarin, an unexpected prolonged PT/INR may prompt review of liver function, vitamin K status and other coagulation tests. Because bleeding and clotting risks can be serious, urgent symptoms should be assessed clinically rather than managed through website ranges.

PT/INR may be requested to assess one part of the clotting system, to monitor warfarin therapy, or when a clinician is investigating bleeding, liver-related clotting changes or pre-procedure coagulation status.

PT measures clotting through the extrinsic/common pathway, while INR standardizes PT so warfarin monitoring is more comparable between laboratories. In people not taking anticoagulants, INR is usually close to 1.0. For many—but not all—warfarin indications, a target INR of 2.0–3.0 is common. The individual's prescribed target is the only target that should guide dosing.

A prolonged PT/INR can have several causes, including anticoagulant effect, vitamin K deficiency and liver-related changes. Interpretation depends on medicines, bleeding history, the clinical reason for testing and sometimes additional coagulation tests.

A web reference range must never be used to adjust warfarin or other anticoagulant doses. PT/INR is designed primarily for vitamin-K-antagonist monitoring and does not reliably measure the effect of every anticoagulant medicine. A normal PT/INR also does not exclude every bleeding disorder; platelet count, aPTT or other specialised tests may be needed.

PT/INR uses citrated blood and the tube must be filled correctly because the blood-to-anticoagulant ratio matters. Fasting is not required. Patients taking warfarin should follow their anticoagulation clinic’s timing and dosing instructions and should not change medicine based on a website range.